Copyright
©The Author(s) 2023.
World J Gastrointest Oncol. Dec 15, 2023; 15(12): 2101-2110
Published online Dec 15, 2023. doi: 10.4251/wjgo.v15.i12.2101
Published online Dec 15, 2023. doi: 10.4251/wjgo.v15.i12.2101
Group | n | 4 h following surgery | 12 h following surgery | 24 h following surgery | 48 h following surgery |
Observation group | 51 | 3.65 ± 0.58 | 2.74 ± 0.47 | 1.97 ± 0.53 | 1.02 ± 0.41 |
Control group | 51 | 3.87 ± 0.62 | 3.29 ± 0.23 | 2.54 ± 0.47 | 1.65 ± 0.32 |
t/χ2 | 1.851 | 7.506 | 5.746 | 8.651 | |
P value | 0.067 | < 0.001 | < 0.001 | < 0.001 |
- Citation: Liu J, Tian JM, Liu GZ, Sun JN, Gao PF, Zhang YQ, Yue XQ. Application of remimazolam transversus abdominis plane block in gastrointestinal tumor surgery. World J Gastrointest Oncol 2023; 15(12): 2101-2110
- URL: https://www.wjgnet.com/1948-5204/full/v15/i12/2101.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v15.i12.2101